Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating [Seeking Alpha]
Scholar Rock Holding Corporation (SRRK)
Last scholar rock holding corporation earnings: 11/12 07:30 am
Check Earnings Report
Company Research
Source: Seeking Alpha
FDA setbacks are manufacturing-related, not clinical, with no new efficacy or safety concerns; remediation and a second CDMO are underway. Topline phase 3 data support apitegromab's novel mechanism and broad label potential, materially expanding SRRK's addressable market and pricing power. SRRK's risks include potential further manufacturing delays, regulatory timing uncertainties, and possible capital raises if approval is postponed beyond the 2027 cash runway. Luis Alvarez/DigitalVision via Getty Images Maintaining a buy rating I am maintaining a buy rating on Scholar Rock ( SRRK ) moving into 2026 as I believe the approval of apitegromab is an issue of "when" rather than "if." I This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of SRRK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Se
Show less
Read more
Impact Snapshot
Event Time:
SRRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRRK alerts
High impacting Scholar Rock Holding Corporation news events
Weekly update
A roundup of the hottest topics
SRRK
News
- Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.MarketBeat
- Scholar Rock Highlights 2026 Strategic Priorities [Yahoo! Finance]Yahoo! Finance
- Scholar Rock Highlights 2026 Strategic PrioritiesBusiness Wire
- Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.MarketBeat
SRRK
Earnings
- 11/14/25 - Miss
SRRK
Sec Filings
- 1/16/26 - Form 4
- 1/15/26 - Form 4
- 1/15/26 - Form 4
- SRRK's page on the SEC website